US Drug Recall Register

FDA Drug Recalls

1,523 recalls · Class III, newest first

Class III · Low risk Terminated

Make Up Transparent dark tan

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1104-2017
Class III · Low risk Terminated

Make Up Perfect caramel

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1103-2017
Class III · Low risk Terminated

Make Up Transparent sand

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1102-2017
Class III · Low risk Terminated

Make Up Transparent pastel

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1101-2017
Class III · Low risk Terminated

Make Up Transparent ivory

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1100-2017
Class III · Low risk Terminated

Beautipharm Eye Care Balm SPF 10

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1099-2017
Class III · Low risk Terminated

Beautipharm Body Moisturizing Balm SPF 10

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1098-2017
Class III · Low risk Terminated

Beautipharm All Day Moisturizing Balm SPF 10

Reason Subpotent Drug: products are labeled as having SPF 10 protection; however, this claim cannot be 100% guaranteed.

Linde Eckstein Gmbh + Co KG D-1097-2017
Class III · Low risk Terminated

Halyard 24-Hour Oral Care Kit q4

Reason Crystallization with subpotent out of specification assay results for chlorhexidine.

Akorn Inc D-1090-2017
Class III · Low risk Terminated

Halyard 24-Hour Oral Care Kit q2

Reason Crystallization with subpotent out of specification assay results for chlorhexidine.

Akorn Inc D-1089-2017
Class III · Low risk Terminated

Chlorhexidine Gluconate Oral Rinse

Reason Crystallization with subpotent out of specification assay results for chlorhexidine.

Akorn Inc NDC 50383-720-15 D-1088-2017
Class III · Low risk Terminated

Deferoxamine Mesylate for injection

Reason CGMP Deviations: Firm failed to control impurity for color change at the API stage.

Pfizer Inc. NDC 0406-2336-10 D-0001-2018
Class III · Low risk Terminated

Pravastatin Sodium Tablets

Reason Failed Impurities/Degradation Specifications: high out of specification results for related impurity for lot C700220.

Dr. Reddy's Laboratories, Inc. NDC 55111-229-90 D-1038-2017
Class III · Low risk Terminated

Argatroban Injection

Reason Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point

Hospira Inc., A Pfizer Company NDC 0409-1140-01 D-0980-2017
Class III · Low risk Terminated

Buprenorphine and Naloxone Sublingual Tablets

Reason Failed Impurities/Degradation Specifications: out of specification test results for related compounds largest unknown impurity.

Teva Pharmaceuticals USA NDC 0093-5720-56 D-0983-2017
Class III · Low risk Terminated

Obagi-C Rx System C-Therapy Night Cream

Reason Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete packaging/labeling. The bottle is missing the product insert and outer carton which contain the complete instruction for use and safety information.

Valeant Pharmaceuticals North America LLC NDC 62032-222-02 D-0998-2017
Class III · Low risk Terminated

Paroxetine Extended-Release Tablets USP

Reason Failed Dissolution Specifications: out of specification observed in dissolution testing at 3 month long term stability study.

Lupin Pharmaceuticals Inc. D-0974-2017
Class III · Low risk Terminated

Amitriptyline HCl Tablets

Reason Cross Contamination With Other Product: Imipramine

Sandoz Incorporated NDC 0781-1487-01 D-0943-2017
Class III · Low risk Terminated

Gaviscon

Reason Superpotent Drug: high out-of-specification result for magnesium.

Sanofi-Aventis U.S. LLC D-0926-2017
Class III · Low risk Terminated

Walgreens Daytime and Nighttime Cold & Flu

Reason Labeling: Label Mix-Up - This product is being recalled due to an incorrect product sleeve on the product twin pack. The incorrect product sleeve is for Day-Night Cold and Flu whereas the batch contains Day-Night Cough Liquid.

L. Perrigo Company D-0925-2017
Class III · Low risk Terminated

G & W Clobetasol Propionate Ointment 0.05%

Reason Failed impurities/degradation specifications: This product is being recalled due to out of specification results for Clobetasol Related Compound A, a known impurity which is a degradation product.

G & W Laboratories, Inc. NDC 0713-0656-15 D-0945-2017
Class III · Low risk Terminated

BuPROPion HCL Tablets

Reason Failed Moisture Limits: Product tested out-of-specification for moisture content.

Mckesson Packaging Services D-0928-2017
Class III · Low risk Terminated

Ponstel

Reason Failed Dissolution Specifications: Low dissolution results were obtained during stability testing

Shionogi Inc. D-0982-2017
Class III · Low risk Terminated

Mefenamic Acid

Reason Failed Dissolution Specifications: Low dissolution results were obtained during stability testing

Shionogi Inc. NDC 66993-070-30 D-0981-2017